Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells.
about
Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasmThe role of Src in solid tumorsDifferential regulation of EphA2 in normal and malignant cellsTyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer.ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinasesSignaling via Shc family adapter proteinsCsk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activationMolecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycleRole of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesisSpatiotemporal regulation of Src and its substrates at invadosomesThe C terminus of c-Src inhibits breast tumor cell growth by a kinase-independent mechanism.Regulation of c-SRC activity and function by the adapter protein CASSrc family kinases and HER2 interactions in human breast cancer cell growth and survival.Novel activation of STAT5b in response to epidermal growth factor.STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3.Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cellsFunctional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferationA switch role of Src in the biphasic EGF signaling of ER-negative breast cancer cells.Epidermal growth factor receptor translocation to the mitochondria: regulation and effect.Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II.Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.Pathways to tamoxifen resistance.An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity.Mechanism of biological synergy between cellular Src and epidermal growth factor receptorc-Src-mediated epithelial cell migration and invasion regulated by PDZ binding site.Rapid screening of protein profiles of human breast cancer cell lines using non-porous reversed-phase high performance liquid chromatography separation with matrix-assisted laser desorption/ionization time-of-flight mass spectral analysis.Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell linesErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor.p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancerSerum starvation regulates E-cadherin upregulation via activation of c-Src in non-small-cell lung cancer A549 cells.Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptorsCombined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growthThe SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane.SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatmentCa2+/Calmodulin and Apo-Calmodulin Both Bind to and Enhance the Tyrosine Kinase Activity of c-Src
P2860
Q24297348-0C70F155-C151-495E-A63B-61DC067E645FQ24616659-B2B171CF-E1CD-45D2-95F2-E4812F68FCF8Q24684095-88261FC8-A1D0-4FBC-AB6F-C086F610A367Q24803054-BA7047FC-3FF0-4140-917D-6AB1EF98C330Q28198475-C7647922-2594-4E47-BED2-D93700509410Q28199357-7F271E53-547D-43E5-91A2-B5F3A45DDEECQ28236497-26E14FF8-AD12-4D03-AB80-CEF035D198D2Q28241105-4AD61D16-4ACE-43E3-92B8-D05BCFAA5BF8Q28288381-5C4272C9-1458-412F-93CF-E3748E64A8F1Q28391160-AAABE971-9959-4223-9485-E7155DD40121Q30164215-A1B06085-8DC9-44CE-9CD2-F720DC28960CQ30168872-52681C06-E59F-4BC5-9813-792E320E85F8Q30307291-9665DC96-C2B4-4183-836E-09D66D173EDBQ30308408-CFBBF7D9-AA52-48F8-B2EC-7FFB8A94BD6AQ30310214-4CC5A5A8-E295-4A4D-8815-A62A0D3DE6CFQ30310839-7E244F55-CA73-43CB-BADD-BE045F4EEAC4Q30415408-D9773FCF-F272-485F-AA6B-E3372A465102Q30424954-2E5FF57F-D18E-4667-8B61-5CAB6A1C87DEQ30425410-003EE4E9-16F0-40B7-9119-A0589EA9079CQ30433793-71180B12-2449-4180-B9D4-E6204B3A5E66Q30434083-696C0AA4-72D2-4CA8-AA0D-A6BD832601E4Q30439082-25E7E224-9D28-4061-83E0-C1377891AB5CQ30441001-EF449A8A-1604-4B67-936E-2167F961FBAEQ30449907-5E2A4BE0-45A6-43BB-A224-8624173A9AC5Q30454480-F50ACEA1-EE6A-4D1A-A583-E20345A63E3CQ30481162-0B0D5B23-5221-4D7B-B80B-3599518A702BQ30770017-CBEC7F90-8AF2-4A48-8008-F860D2866F20Q33822560-FC708CA2-1CE8-4203-9E73-2EF8139AE4DCQ33907679-6CA10816-E0AF-491A-A151-193236EB5802Q33960257-1DF771CC-109D-4AEF-96F3-8B3CC0E609D0Q34015848-AFF97F41-D29F-4B42-9C02-55F5DBA5B314Q34387697-4A498308-6622-4B29-AC40-04C98E8279F2Q34439502-254C1E1F-2272-4EEF-ADC1-BE79BEB54603Q34502396-66A29331-6FDE-4D9B-8018-68008ED22720Q34806104-187CEC88-B2C0-4A5B-8E76-9E25E4F1CA35Q34812100-2A6F42EA-E2EB-4DAF-90F5-548BF2FBEC36Q34966503-373B2CA4-4AAC-40DC-BF94-FDFD711AC3C4Q35081216-AD901FCC-532F-4C2D-8367-A036B4AD6827Q35113027-5DA959B9-F2B1-4862-8569-389D5DFB77C8Q35658526-45004489-55B9-401D-B73F-EF489E71E402
P2860
Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Characterization of human epid ...... s in human breast tumor cells.
@ast
Characterization of human epid ...... s in human breast tumor cells.
@en
type
label
Characterization of human epid ...... s in human breast tumor cells.
@ast
Characterization of human epid ...... s in human breast tumor cells.
@en
prefLabel
Characterization of human epid ...... s in human breast tumor cells.
@ast
Characterization of human epid ...... s in human breast tumor cells.
@en
P2093
P2860
P1476
Characterization of human epid ...... s in human breast tumor cells.
@en
P2093
Belsches AP
Biscardi JS
Parsons SJ
P2860
P304
P356
10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N
P577
1998-04-01T00:00:00Z